An injectable hydrogel platform shows promise in local immunotherapy for triple-negative breast cancer, enhancing treatment efficacy with lower toxicity.
An injectable hydrogel platform shows promise in local immunotherapy for triple-negative breast cancer, enhancing treatment efficacy with lower toxicity.